# Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

> **NCT01638026** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 93 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** TRIPTORELIN ACETATE, hCG

## Key facts

- **NCT ID:** NCT01638026
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2017-07
- **Final completion:** 2017-08
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638026, "Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01638026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*